Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on: November 09,2024

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on:November 09,2024

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on: December 02,2024

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on:December 02,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on: February 03,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on:February 03,2024

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on: November 11,2024

Study finds novel role of BRCA1 in tumor suppression

by Steven Lee,University of Texas Health Science Center at San AntonioSingle-molecule analysis of BRCA1–BARD1 in BLM- and EXO1-dependent resection. Credit:Nature(2024). DOI: 10.1038/

Updated on:November 11,2024

New therapeutic approach for the treatment of neuroblastoma in young children

by Jonas Machner, Universitätsmedizin HalleLead author Sven Hagemann is handling cell cultures. Credit: University Medicine HalleNeuroblastomas are tumors of the nervous system. They can form in many

Updated on: February 18,2024

New therapeutic approach for the treatment of neuroblastoma in young children

by Jonas Machner, Universitätsmedizin HalleLead author Sven Hagemann is handling cell cultures. Credit: University Medicine HalleNeuroblastomas are tumors of the nervous system. They can form in many

Updated on:February 18,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on: January 29,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on:January 29,2024

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on: February 20,2024

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on:February 20,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on: April 28,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on:April 28,2024

Experts call for adequate tumor-free margins in breast cancer surgery to reduce recurrence and improve survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainSurgeons should aim to remove at least a 1-mm width rim (margin) of healthy tissue around a breast tumor to reduce the risk of cancer re

Updated on: January 22,2024

Experts call for adequate tumor-free margins in breast cancer surgery to reduce recurrence and improve survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainSurgeons should aim to remove at least a 1-mm width rim (margin) of healthy tissue around a breast tumor to reduce the risk of cancer re

Updated on:January 22,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on: April 28,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on:April 28,2024

Firefighters far more likely to die from cancer and heart attacks than the public, finds study

by University of Central LancashireCredit: Pixabay/CC0 Public DomainA new study commissioned by the Fire Brigades Union (FBU) and independently carried out by the University of Central Lancashire

Updated on: February 18,2024

Firefighters far more likely to die from cancer and heart attacks than the public, finds study

by University of Central LancashireCredit: Pixabay/CC0 Public DomainA new study commissioned by the Fire Brigades Union (FBU) and independently carried out by the University of Central Lancashire

Updated on:February 18,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on: August 28,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on:August 28,2024